Article
5-HT1B receptor polymorphism and clinical response to sumatriptan.
Headache - 1 Apr 1998
MaassenVanDenBrink A, Vergouwe M N, Ophoff R A, Saxena P R, Ferrari M D, Frants R R
Abstract excerpt
The 5-HT1 receptor agonist, sumatriptan, is highly effective in the treatment of migraine. Some patients, however, do not respond or experience recurrence of the headache. In addition, some patients report chest symptoms after sumatriptan. We investigated whether these different responses could be attributed to genetic diversity of the 5-HT1B receptor, which most likely mediates the therapeutic action and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
